|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
decreases expression multiple interactions |
ISO |
Pentoxifylline results in decreased expression of ABCB1 protein [Pentoxifylline co-treated with Doxorubicin] results in decreased expression of ABCB1 protein |
CTD |
PMID:33775688 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
multiple interactions |
ISO |
[Pentoxifylline co-treated with Doxorubicin] results in decreased expression of ABCC1 protein |
CTD |
PMID:33775688 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO |
Pentoxifylline results in decreased activity of ACHE protein |
CTD |
PMID:11981227 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
decreases expression multiple interactions |
ISO |
Pentoxifylline results in decreased expression of ACTA2 protein Pentoxifylline promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] |
CTD |
PMID:14996430 PMID:18207697 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of BAX protein] |
CTD |
PMID:37431890 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
[Rolipram co-treated with Pentoxifylline] inhibits the reaction [Streptozocin results in increased expression of BCL2 protein]; Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of BCL2 protein] |
CTD |
PMID:37431890 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions decreases expression |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein Pentoxifylline results in decreased expression of BCL2L1 mRNA; Pentoxifylline results in decreased expression of BCL2L1 protein |
CTD |
PMID:18851957 PMID:20804743 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Pentoxifylline promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein] |
CTD |
PMID:20804743 |
|
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC2 protein |
CTD |
PMID:20804743 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC3 protein |
CTD |
PMID:20804743 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Braf |
Braf transforming gene |
multiple interactions |
ISO |
[Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased activity of BRAF protein |
CTD |
PMID:21693435 |
|
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased cleavage of CASP1 protein] |
CTD |
PMID:36690085 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
Pentoxifylline inhibits the reaction [Ethanol results in increased activity of CASP3 protein] Pentoxifylline results in increased activity of CASP3 protein [Pentoxifylline co-treated with Doxorubicin] results in increased cleavage of CASP3 protein [Rolipram co-treated with Pentoxifylline] inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; Pentoxifylline inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein] |
CTD |
PMID:16317704 PMID:18851957 PMID:33775688 PMID:37431890 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Pentoxifylline promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] |
CTD |
PMID:20804743 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in increased activity of CASP9 protein |
CTD |
PMID:20804743 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions |
EXP ISO |
[Melatonin co-treated with Pentoxifylline] inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein]; Pentoxifylline inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] Pentoxifylline inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; Pentoxifylline inhibits the reaction [Malathion results in increased activity of CAT protein] |
CTD |
PMID:16703270 PMID:20194575 PMID:23695977 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression decreases secretion |
ISO |
Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] Pentoxifylline results in decreased expression of CCL2 mRNA Pentoxifylline results in decreased secretion of CCL2 protein |
CTD |
PMID:14993492 PMID:18617301 PMID:19921414 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of CCL5 mRNA |
CTD |
PMID:14993492 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of CCN2 mRNA |
CTD |
PMID:11788567 |
|
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Mechlorethamine results in increased activity of [CCNA2 protein binds to CDK2 protein]] |
CTD |
PMID:8463339 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]] |
CTD |
PMID:8463339 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Cd69 |
CD69 antigen |
decreases expression |
EXP |
Pentoxifylline results in decreased expression of CD69 protein |
CTD |
PMID:25433234 |
|
NCBI chr 6:129,244,287...129,252,332
Ensembl chr 6:129,244,288...129,252,399
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]] |
CTD |
PMID:8463339 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Mechlorethamine results in increased activity of [CCNA2 protein binds to CDK2 protein]] |
CTD |
PMID:8463339 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein |
CTD |
PMID:21693435 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein Pentoxifylline results in decreased expression of CFLAR protein |
CTD |
PMID:18851957 PMID:20804743 |
|
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
|
|
G |
Ckm |
creatine kinase, muscle |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased secretion of CKM protein] |
CTD |
PMID:36690085 |
|
NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
multiple interactions decreases expression |
ISO |
Pentoxifylline inhibits the reaction [Acetaldehyde results in increased expression of COL1A1 mRNA] Pentoxifylline results in decreased expression of COL1A1 mRNA Pentoxifylline promotes the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA] |
CTD |
PMID:7617123 PMID:11788567 PMID:12419648 PMID:14993492 PMID:17952619 PMID:18207697 More...
|
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of COL3A1 protein |
CTD |
PMID:11788567 |
|
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of CRP protein |
CTD |
PMID:14970111 |
|
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [[Ranitidine co-treated with Lipopolysaccharides] results in increased expression of CXCL2 protein] |
CTD |
PMID:17698507 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cycs |
cytochrome c, somatic |
increases secretion multiple interactions |
ISO |
Pentoxifylline results in increased secretion of CYCS protein Pentoxifylline promotes the reaction [TNFSF10 protein results in increased secretion of CYCS protein] |
CTD |
PMID:18851957 PMID:20804743 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Pentoxifylline results in decreased activity of CYP1A2 protein |
CTD |
PMID:11465391 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression decreases expression |
ISO |
Pentoxifylline results in increased expression of FAS mRNA; Pentoxifylline results in increased expression of FAS protein Pentoxifylline results in decreased expression of FAS protein |
CTD |
PMID:14970111 PMID:18851957 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
ISO |
Pentoxifylline results in increased expression of FOS mRNA |
CTD |
PMID:18851957 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
Pentoxifylline results in increased expression of GADD45A mRNA |
CTD |
PMID:18851957 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased cleavage of GSDMD protein] |
CTD |
PMID:36690085 |
|
NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of and results in increased secretion of HAVCR1 protein] |
CTD |
PMID:32777238 |
|
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of HMOX1 protein |
CTD |
PMID:22461696 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of ICAM1 mRNA |
CTD |
PMID:14993492 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
Pentoxifylline promotes the reaction [Zymosan results in increased expression of IL10 protein] |
CTD |
PMID:11301049 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
Pentoxifylline promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Pentoxifylline inhibits the reaction [Cyclophosphamide results in increased expression of IL1B protein]; Pentoxifylline inhibits the reaction [Glycerol results in increased cleavage of IL1B protein]; Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of IL1B protein]; Pentoxifylline inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] |
CTD |
PMID:15711975 PMID:16133968 PMID:17167242 PMID:17698507 PMID:23695977 PMID:36690085 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il2ra |
interleukin 2 receptor, alpha chain |
multiple interactions decreases expression decreases secretion |
ISO EXP |
N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide inhibits the reaction [Pentoxifylline results in decreased expression of IL2RA protein] Pentoxifylline results in decreased expression of IL2RA mRNA; Pentoxifylline results in decreased expression of IL2RA protein Pentoxifylline results in decreased secretion of IL2RA protein |
CTD |
PMID:1709825 PMID:25433234 |
|
NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
Pentoxifylline results in increased expression of IL4 mRNA |
CTD |
PMID:7589090 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] Acetaldehyde promotes the reaction [Pentoxifylline results in decreased expression of IL6 mRNA]; Pentoxifylline inhibits the reaction [Acetaldehyde results in increased expression of IL6 mRNA]; Pentoxifylline inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]; Pentoxifylline inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA] |
CTD |
PMID:12419648 PMID:15711975 PMID:17167242 PMID:17698507 PMID:17952619 PMID:23695977 More...
|
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Itgb2 |
integrin beta 2 |
affects expression |
ISO |
Pentoxifylline affects the expression of ITGB2 |
CTD |
PMID:1976392 |
|
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MAP1LC3B protein modified form] |
CTD |
PMID:32777238 |
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
multiple interactions affects binding |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of MAP3K7 protein] Pentoxifylline binds to MAP3K7 protein |
CTD |
PMID:32777238 |
|
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:19697996 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:19697996 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression |
ISO |
Pentoxifylline results in increased expression of MAPK8 protein; Pentoxifylline results in increased expression of MAPK8 protein modified form |
CTD |
PMID:20804743 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases expression |
ISO |
Pentoxifylline results in increased expression of MAPK9 protein; Pentoxifylline results in increased expression of MAPK9 protein modified form |
CTD |
PMID:20804743 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
increases expression |
ISO |
Pentoxifylline results in increased expression of MCL1 mRNA |
CTD |
PMID:18851957 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Mir26b |
microRNA 26b |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MIR26B mRNA] |
CTD |
PMID:32777238 |
|
NCBI chr 1:74,433,469...74,433,553
Ensembl chr 1:74,433,469...74,433,553
|
|
G |
Mir34a |
microRNA 34a |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of MIR34A mRNA] |
CTD |
PMID:32777238 |
|
NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
|
|
G |
Mirlet7b |
microRNA let7b |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MIRLET7B mRNA] |
CTD |
PMID:32777238 |
|
NCBI chr15:85,591,520...85,591,604
Ensembl chr15:85,591,520...85,591,604
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Indomethacin results in increased activity of MPO protein] |
CTD |
PMID:16133968 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of MTOR protein] |
CTD |
PMID:32777238 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Myc |
myelocytomatosis oncogene |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased expression of MYC protein] |
CTD |
PMID:36690085 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:17952619 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Acetaldehyde results in decreased expression of NFKBIA protein]; Pentoxifylline inhibits the reaction [Acetaldehyde results in increased degradation of NFKBIA protein] |
CTD |
PMID:17952619 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased expression of NLRP3 protein] |
CTD |
PMID:36690085 |
|
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] |
CTD |
PMID:16133968 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nppb |
natriuretic peptide type B |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of NPPB protein |
CTD |
PMID:14970111 |
|
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions increases cleavage |
ISO |
[Pentoxifylline co-treated with Doxorubicin] results in increased cleavage of PARP1 protein; Pentoxifylline promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] Pentoxifylline results in increased cleavage of PARP1 protein |
CTD |
PMID:18851957 PMID:20804743 PMID:33775688 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Prf1 |
perforin 1 (pore forming protein) |
decreases secretion |
ISO |
Pentoxifylline results in decreased secretion of PRF1 protein |
CTD |
PMID:17880773 |
|
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
|
|
G |
Psma1 |
proteasome subunit alpha 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Monocrotaline results in increased expression of PSMA1 mRNA] |
CTD |
PMID:18801959 |
|
NCBI chr 7:113,863,785...113,875,351
Ensembl chr 7:113,863,841...113,875,353
|
|
G |
Psma3 |
proteasome subunit alpha 3 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Monocrotaline results in increased expression of PSMA3 mRNA] |
CTD |
PMID:18801959 |
|
NCBI chr12:71,016,082...71,042,651
Ensembl chr12:71,021,395...71,043,121
|
|
G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Monocrotaline results in increased expression of PSMC6 mRNA] |
CTD |
PMID:18801959 |
|
NCBI chr14:45,567,285...45,587,150
Ensembl chr14:45,567,245...45,587,162
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein] |
CTD |
PMID:17638016 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rap1b |
RAS related protein 1b |
multiple interactions |
ISO |
[Pentoxifylline results in increased abundance of Cyclic AMP] results in increased abundance of [RAP1B protein binds to Guanosine Triphosphate] |
CTD |
PMID:21693435 |
|
NCBI chr10:117,650,502...117,681,879
Ensembl chr10:117,649,776...117,681,940
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
EXP ISO |
Pentoxifylline inhibits the reaction and results in decreased activity of Ethanol inhibits the reaction and results in decreased activity of RELA protein Pentoxifylline inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]]; Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of RELA protein] [Pentoxifylline co-treated with Doxorubicin] results in decreased phosphorylation of RELA protein |
CTD |
PMID:16317704 PMID:17952619 PMID:32777238 PMID:33775688 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 protein]] |
CTD |
PMID:17698507 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of SPP1 mRNA |
CTD |
PMID:14993492 |
|
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression multiple interactions |
ISO |
Pentoxifylline results in decreased expression of TGFB1 mRNA Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of TGFB1 protein] |
CTD |
PMID:11788567 PMID:32777238 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor I |
affects binding multiple interactions |
ISO |
Pentoxifylline binds to TGFBR1 protein Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of TGFBR1 mRNA]; Pentoxifylline inhibits the reaction [Cisplatin results in increased expression of TGFBR1 protein] |
CTD |
PMID:32777238 |
|
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
increases expression |
ISO |
Pentoxifylline results in increased expression of TIMP1 mRNA |
CTD |
PMID:11788567 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Pentoxifylline inhibits the reaction [Glycerol results in increased expression of TLR4 protein] |
CTD |
PMID:36690085 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions decreases secretion increases expression |
ISO EXP |
Pentoxifylline results in decreased expression of TNF mRNA; Pentoxifylline results in decreased expression of TNF protein Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Pentoxifylline results in decreased secretion of TNF protein Pentoxifylline results in increased expression of TNF protein [Pentoxifylline results in decreased expression of TNF mRNA] results in decreased susceptibility to [lipopolysaccharide, E coli O55-B5 co-treated with trovafloxacin]; Pentoxifylline inhibits the reaction [endotoxin, Escherichia coli results in increased expression of TNF mRNA]; Pentoxifylline inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of TNF protein]; Pentoxifylline inhibits the reaction [Ethanol results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; Pentoxifylline inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Pentoxifylline inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Pentoxifylline inhibits the reaction [Zymosan results in increased expression of TNF protein] Pentoxifylline inhibits the reaction [Ceruletide results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [Glycerol results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Pentoxifylline inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] |
CTD |
PMID:1593221 PMID:7589090 PMID:7769305 PMID:8741040 PMID:10773043 PMID:10996031 PMID:11301049 PMID:11508396 PMID:14970111 PMID:14993492 PMID:15060681 PMID:15601679 PMID:15711975 PMID:16133968 PMID:16317704 PMID:16581537 PMID:17167242 PMID:17698507 PMID:17709330 PMID:18617301 PMID:21767162 PMID:23695977 PMID:36690085 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
increases expression |
ISO |
Pentoxifylline results in increased expression of TNFRSF10A protein |
CTD |
PMID:20804743 |
|
NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
multiple interactions increases expression |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein; [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC2 protein; [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BIRC3 protein; [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein; [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of XIAP protein; [Pentoxifylline co-treated with TNFSF10 protein] results in increased activity of CASP9 protein; Pentoxifylline promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Pentoxifylline promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein]; Pentoxifylline promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; Pentoxifylline promotes the reaction [TNFSF10 protein results in increased secretion of CYCS protein] Pentoxifylline results in increased expression of TNFSF10 mRNA |
CTD |
PMID:18851957 PMID:20804743 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of VCAM1 mRNA |
CTD |
PMID:14720322 |
|
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Pentoxifylline results in decreased expression of VEGFA mRNA |
CTD |
PMID:14720322 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
[Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of XIAP protein |
CTD |
PMID:20804743 |
|
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
|
|